Some studies reported that the combination of statins with PPAR agonists show additional beneficial effects on adverse stroke outcome, especially in cases of high risk groups with, e.g., atherogenic dyslipidemia (Montaner et al., 2008; van der Most et al., 2009; Castilla-Guerra and Fernandez-Moreno Mdel, 2015). Here, PPARA is linked to Stroke.